Modified ciliary neurotrophic factor (CNTF) with reduced immunogenicity

Details for Australian Patent Application No. 2002254910 (hide)

Owner MERCK PATENT GMBH

Inventors Carter, Graham.; Carr, Francis J.

Agent Davies Collison Cave

Pub. Number AU-A-2002254910

PCT Pub. Number WO2002/070698

Priority 01105089.5 02.03.01 EP

Filing date 27 February 2002

Wipo publication date 19 September 2002

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C07K 014/475 Peptides having more than 20 amino acids

A61K 038/18 Medicinal preparations containing peptides - Growth factors

Event Publications

13 March 2003 Application Open to Public Inspection

  Published as AU-A-2002254910

25 October 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002254911-Bicyclic guanidine derivatives and therapeutics uses thereof

2002254909-Salts of avermectins substituted in the 4"-position and having pesticidal properties